Sarepta’s Duchenne Muscular Dystrophy Therapy Wins FDA Approval

Posted by ISPE Boston
On March 10, 2021

The FDA has approved Sarepta Therapeutics Amondys 45, an antisense oligonucleotide, for the treatment of Duchenne muscular dystrophy (DMD) in certain patients. Consistent with the accelerated approval pathway, the continued approval of Amondys 45 may be contingent on confirmation of a clinical benefit in confirmatory trials. The Essence trial – a placebo-controlled confirmatory trial to […]

Apply Today: Mass Life Sciences Center’s Program Deadlines

Posted by ISPE Boston
On March 10, 2021

The Massachusetts Life Sciences Center’s portfolio of programs has strategically deployed more than $700 million in Massachusetts, through a combination of grants, loans, capital infrastructure investments, tax incentives, and workforce programs. These investments have created thousands of jobs, and propelled the development of new therapies, devices, and scientific advancements that are improving patient health and […]

Mass Maritime Students Seeking Jobs for Summer Co-op Term

Posted by ISPE Boston
On March 10, 2021

Spring is just around the corner and Massachusetts Maritime Academy Career Services is preparing for our Summer 2021 Co-op term! We are beginning to post internship opportunities for our shore-side programs and hope that you will consider sponsoring one of our students. This summer our co-op term is running from May 24 to August 27, […]

Bypass Your Inner Critic in Public Speaking: How to Speak Up with Confidence, Even Online!

Posted by Caren Jenkins
On March 4, 2021

WIP Boston is proud to present an encore presentation of “How to be a Better Public Speaker” on Wednesday, March 31 at 5:30pm. Once again, Mary Cheyne fabulously presents her updated program on public speaking with a focus on virtual public speaking. The new program is titled “Bypass Your Inner Critic in Public Speaking: How […]

Chapter Member Anniversaries: March 2021

Posted by ISPE Boston
On March 4, 2021

Please congratulate the following members celebrating milestone anniversaries in March 2021. Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years Saboo Aghababayan, MS, MBA, Genzyme Stig Bockman-Pedersen, CCQV Services Matthew J. Camelio, Thermo Fisher Ronald C. Case, RCC Associates Dr. Charles L. Cooney, PhD, MIT Chemical Engineering […]

Welcome New Members February 2021!

Posted by ISPE Boston
On March 4, 2021

We would like to introduce the Members who joined ISPE in February 2021, welcome them to the Chapter and encourage them (and all of our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges. And […]

Pandion Therapeutics to be Acquired by Merck

Posted by ISPE Boston
On March 3, 2021

Merck and Watertown-based Pandion Therapeutics, a clinical-stage biotech developing novel therapeutics targeting autoimmune diseases, have agreed that Merck will acquire Pandion for $60 per share or approximately $1.85 billion. The transaction is expected to close in the first half of 2021. Pandion is advancing a pipeline of precision immune modulators targeting critical immune control nodes. […]

Beam Therapeutics Buys Drug Delivery Biotech

Posted by ISPE Boston
On March 3, 2021

Gene-editing biotech Beam Therapeutics has acquired Guide Therapeutics, a developer of nonviral drug delivery vehicles for genetic medicines, further expanding the potential reach of Beam’s genetic medicines into new target tissues and diseases. “Since our founding, Beam’s strategy has been to establish the leading, fully integrated platform for precision genetic medicine,” said Beam CEO John […]

Ensoma Launches, Enters Collaboration with Takeda

Posted by ISPE Boston
On March 3, 2021

Boston-based Ensoma, formally launched in early February, has entered into a strategic collaboration with Takeda. The agreement grants Takeda an exclusive worldwide license to Ensoma’s Engenious™ vectors for up to five rare disease indications. Takeda will make an equity investment of $10 million in Ensoma’s Series A Preferred Stock with the potential for $100 million […]

Get Involved! Volunteer with ISPE Today

Posted by ISPE Boston
On February 22, 2021

Had enough of social isolation? Bored with talking to your cat instead of colleagues? Are you feeling like you need to change out of sweatpants? We can’t promise that you will never attend a Zoom meeting, but we can promise that you will connect with some of the nicest folks in the biopharma industry and […]

Page 52 of 118«‹50 515253 54 ›»